<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Hypogonadism is either hypergonadotropic (primary) or hypogonadotropic (secondary). When the pituitary gland is secreting an excess of gonadotropins, primary hypogonadism is diagnosed. In secondary hypogonadism, the levels of gonadotro-pins in the serum remain low. Male patients affected with hypogonadism present numerous symptoms due to a lack of testosterone, e.g., erectile impairment, feminization of the body, and infertility. The deterioration of self-confidence and quality of life underlines the importance of the correct diagnosis and effective treatment. Clomiphene citrate is registered in Europe for the treatment of ovulatory failure in women. It is often used as an off-label drug to treat hypogonadism in men, as it proves efficient in some cases and is relatively safe and easily administered in comparison to other medicaments, e.g., testosterone and gonadotropin analogs. We report on a 35-year-old Caucasian male patient who was admitted to the Department of Endocrinology with symptoms of erectile dysfunction, lowered self-esteem, hypersomnia, and trouble conceiving. A complex diagnostic procedure was performed, which led to the final diagnosis of hypogonadotropic hypogonadism and reactive hyperprolactinemia. The treatment with Clomiphene Citrate was implemented and brought significant improvement – the withdrawal of unwanted symptoms and restored hormonal balance – after two weeks.</p>
</abstract>

Hypogonadism is either hypergonadotropic (primary) or hypogonadotropic (secondary). When the pituitary gland is secreting an excess of gonadotropins, primary hypogonadism is diagnosed. In secondary hypogonadism, the levels of gonadotro-pins in the serum remain low. Male patients affected with hypogonadism present numerous symptoms due to a lack of testosterone, e.g., erectile impairment, feminization of the body, and infertility. The deterioration of self-confidence and quality of life underlines the importance of the correct diagnosis and effective treatment. Clomiphene citrate is registered in Europe for the treatment of ovulatory failure in women. It is often used as an off-label drug to treat hypogonadism in men, as it proves efficient in some cases and is relatively safe and easily administered in comparison to other medicaments, e.g., testosterone and gonadotropin analogs. We report on a 35-year-old Caucasian male patient who was admitted to the Department of Endocrinology with symptoms of erectile dysfunction, lowered self-esteem, hypersomnia, and trouble conceiving. A complex diagnostic procedure was performed, which led to the final diagnosis of hypogonadotropic hypogonadism and reactive hyperprolactinemia. The treatment with Clomiphene Citrate was implemented and brought significant improvement – the withdrawal of unwanted symptoms and restored hormonal balance – after two weeks.

Off-label Therapy of Hypogonadotropic Hypogonadism in a 35-year-old Male Patient Using Clomiphene Citrate – A Case Study

Student Scientific Society at Department of Endocrinology, Diabetology and Metabolic Diseases

Journal of Health Study and Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Hypogonadism is either hypergonadotropic (primary) or hypogonadotropic (secondary). When the pituitary gland is secreting an excess of gonadotropins, primary...

Off-label Therapy of Hypogonadotropic Hypogonadism in a 35-year-old Male Patient Using Clomiphene Citrate – A Case Study

Pubblicato online: 16 apr 2024

Pagine: 399 - 407

Ricevuto: 22 ago 2023

Accettato: 25 mar 2024

DOI: https://doi.org/10.2478/jhsm-2023-0018

Parole chiave
pregnancy, vitamins, diet, nutrition, supplementation

© 2023 Magdalena Kamińska et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Off-label Therapy of Hypogonadotropic Hypogonadism in a 35-year-old Male Patient Using Clomiphene Citrate – A Case Study

Pubblicato online: 16 apr 2024

Pagine: 399 - 407

Ricevuto: 22 ago 2023

Accettato: 25 mar 2024

DOI: https://doi.org/10.2478/jhsm-2023-0018

Parole chiavepregnancy, vitamins, diet, nutrition, supplementation

© 2023 Magdalena Kamińska et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Parole chiave
pregnancy, vitamins, diet, nutrition, supplementation